Similar articles

• Neuropeptides and airway submucosal gland secretion.

  Shimura S, Sasaki T, Ikeda K, Ishihara H, Sato M, Sasaki H, Takishima T. Shimura S, et al. Am Rev Respir Dis. 1991 Mar;143(3 Pt 2):S25-7. doi: 10.1164/ajrccm/143.3_Pt_2.S25. Am Rev Respir Dis. 1991. PMID: 1706151
• The effect of vasoactive intestinal peptide on smooth muscle tone and mucus secretion from the ferret trachea.

  Webber SE, Widdicombe JG. Webber SE, et al. Br J Pharmacol. 1987 May;91(1):139-48. doi: 10.1111/j.1476-5381.1987.tb08992.x. Br J Pharmacol. 1987. PMID: 3594072 Free PMC article.
• Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro.

  Coles SJ, Said SI, Reid LM. Coles SJ, et al. Am Rev Respir Dis. 1981 Nov;124(5):531-6. doi: 10.1164/arrd.1981.124.5.531. Am Rev Respir Dis. 1981. PMID: 7305106
• Action of a novel drug (Zy 16039) on mucus secretion in the ferret isolated trachea in vitro.

  Webber SE, Widdicombe JG. Webber SE, et al. Agents Actions. 1988 Jun;24(1-2):65-72. doi: 10.1007/BF01968081. Agents Actions. 1988. PMID: 3044031
• Neuropeptides and immunity.

  Stanisz A, Scicchitano R, Stead R, Matsuda H, Tomioka M, Denburg J, Bienenstock J. Stanisz A, et al. Am Rev Respir Dis. 1987 Dec;136(6 Pt 2):S48-51. doi: 10.1164/ajrccm/136.6_Pt_2.S48. Am Rev Respir Dis. 1987. PMID: 2446542 Review.